Concord Drugs Ltd. - Research Center
538965 CONCORD Group (X) BSE data
Add to watchlist
| Results |
Half yearly
|
| Statement | |
| More |
Half yearly results in brief
(Rs crore)
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Sales | 16.17 | 26.25 | 28.86 | 30.10 | 34.77 |
| Operating profit | 2.93 | 2.16 | 1.64 | 3.96 | 1.84 |
| Interest | 0.78 | 0.76 | 0.42 | 1.26 | 0.93 |
| Gross profit | 2.16 | 1.41 | 1.32 | 2.69 | 0.98 |
| EPS (Rs) | 1.09 | 0.42 | 0.51 | 1.31 | 0.28 |
Half yearly
results in details
| Sep ' 23 | Sep ' 22 | Mar ' 22 | Sep ' 21 | Sep ' 20 | |
|---|---|---|---|---|---|
| Other income | 0.01 | 0.01 | 0.10 | - | 0.07 |
| Stock adjustment | -0.33 | 0.76 | -1.77 | -0.54 | 1.23 |
| Raw material | 10.48 | 19.75 | 21.32 | 23.10 | 28.82 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 2.49 | 2.31 | 2.80 | 2.09 | 1.88 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 0.60 | 1.26 | 4.87 | 1.50 | 0.99 |
| Provisions made | - | - | - | - | - |
| Depreciation | 0.76 | 0.92 | 0.67 | 1.10 | 0.65 |
| Taxation | 0.38 | 0.12 | 0.20 | 0.45 | 0.09 |
| Net profit / loss | 1.01 | 0.37 | 0.45 | 1.15 | 0.25 |
| Extra ordinary item | - | - | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 9.32 | 8.74 | 8.74 | 8.74 | 8.74 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 18.11 | 8.23 | 5.67 | 13.14 | 5.30 |
| GPM (%) | 13.32 | 5.36 | 4.56 | - | 2.81 |
| NPM (%) | 6.26 | 1.41 | 1.55 | - | 0.71 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis